Odalasvir
- Generic Name
- Odalasvir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C60H72N8O6
- CAS Number
- 1415119-52-6
- Unique Ingredient Identifier
- OVR52K7BDW
- Background
Odalasvir has been used in trials studying the treatment of Hepatitis C, Chronic and Chronic Hepatitis C Infection.
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of Odalasvir
- First Posted Date
- 2016-11-11
- Last Posted Date
- 2018-05-17
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 16
- Registration Number
- NCT02961660
- Locations
- 🇺🇸
New Orleans Center for Clinical Research, Knoxville, Tennessee, United States
🇺🇸Orlando Clinical Research Center, Orlando, Florida, United States
Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-05-06
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 365
- Registration Number
- NCT02765490
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath